PMID- 26503982 OWN - NLM STAT- MEDLINE DCOM- 20160712 LR - 20160224 IS - 1537-6613 (Electronic) IS - 0022-1899 (Linking) VI - 213 IP - 5 DP - 2016 Mar 1 TI - Verapamil-Sensitive Transport of Quinacrine and Methylene Blue via the Plasmodium falciparum Chloroquine Resistance Transporter Reduces the Parasite's Susceptibility to these Tricyclic Drugs. PG - 800-10 LID - 10.1093/infdis/jiv509 [doi] AB - BACKGROUND: It is becoming increasingly apparent that certain mutations in the Plasmodium falciparum chloroquine resistance transporter (PfCRT) alter the parasite's susceptibility to diverse compounds. Here we investigated the interaction of PfCRT with 3 tricyclic compounds that have been used to treat malaria (quinacrine [QC] and methylene blue [MB]) or to study P. falciparum (acridine orange [AO]). METHODS: We measured the antiplasmodial activities of QC, MB, and AO against chloroquine-resistant and chloroquine-sensitive P. falciparum and determined whether QC and AO affect the accumulation and activity of chloroquine in these parasites. We also assessed the ability of mutant (PfCRT(Dd2)) and wild-type (PfCRT(D10)) variants of the protein to transport QC, MB, and AO when expressed at the surface of Xenopus laevis oocytes. RESULTS: Chloroquine resistance-conferring isoforms of PfCRT reduced the susceptibility of the parasite to QC, MB, and AO. In chloroquine-resistant (but not chloroquine-sensitive) parasites, AO and QC increased the parasite's accumulation of, and susceptibility to, chloroquine. All 3 compounds were shown to bind to PfCRT(Dd2), and the transport of QC and MB via this protein was saturable and inhibited by the chloroquine resistance-reverser verapamil. CONCLUSIONS: Our findings reveal that the PfCRT(Dd2)-mediated transport of tricyclic antimalarials reduces the parasite's susceptibility to these drugs. CI - (c) The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. FAU - van Schalkwyk, Donelly A AU - van Schalkwyk DA AD - Research School of Biology, Australian National University, Canberra, Australia. FAU - Nash, Megan N AU - Nash MN AD - Research School of Biology, Australian National University, Canberra, Australia. FAU - Shafik, Sarah H AU - Shafik SH AD - Research School of Biology, Australian National University, Canberra, Australia. FAU - Summers, Robert L AU - Summers RL AD - Research School of Biology, Australian National University, Canberra, Australia. FAU - Lehane, Adele M AU - Lehane AM AD - Research School of Biology, Australian National University, Canberra, Australia. FAU - Smith, Peter J AU - Smith PJ AD - Division of Pharmacology, Department of Medicine, University of Cape Town, Rondebosch, South Africa. FAU - Martin, Rowena E AU - Martin RE AD - Research School of Biology, Australian National University, Canberra, Australia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151026 PL - United States TA - J Infect Dis JT - The Journal of infectious diseases JID - 0413675 RN - 0 (Antimalarials) RN - 0 (Membrane Transport Proteins) RN - 0 (PfCRT protein, Plasmodium falciparum) RN - 0 (Protozoan Proteins) RN - CJ0O37KU29 (Verapamil) RN - H0C805XYDE (Quinacrine) RN - T42P99266K (Methylene Blue) SB - IM MH - Animals MH - Antimalarials/pharmacology MH - Biological Transport/drug effects MH - Drug Resistance MH - Gene Expression Regulation/physiology MH - Genetic Variation MH - Membrane Transport Proteins/*metabolism MH - Methylene Blue/*metabolism MH - Oocytes/metabolism MH - Plasmodium falciparum/*drug effects/*metabolism MH - Protozoan Proteins/*metabolism MH - Quinacrine/*metabolism MH - Verapamil/*pharmacology MH - Xenopus laevis OTO - NOTNLM OT - PfCRT OT - Plasmodium falciparum OT - Xenopus oocytes OT - drug resistance OT - fluorescence-based transport assay OT - methylene blue OT - tricyclic drug EDAT- 2015/10/28 06:00 MHDA- 2016/07/13 06:00 CRDT- 2015/10/28 06:00 PHST- 2015/09/04 00:00 [received] PHST- 2015/10/15 00:00 [accepted] PHST- 2015/10/28 06:00 [entrez] PHST- 2015/10/28 06:00 [pubmed] PHST- 2016/07/13 06:00 [medline] AID - jiv509 [pii] AID - 10.1093/infdis/jiv509 [doi] PST - ppublish SO - J Infect Dis. 2016 Mar 1;213(5):800-10. doi: 10.1093/infdis/jiv509. Epub 2015 Oct 26.